|
[1]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Jin, H., Wang, H., Li, G., Hou, Q., Wu, W. and Liu, F. (2020) Risk Factors for Early Postoperative Recurrence in Single and Small Hepatitis B Virus-Associated Primary Hepatocellular Carcinoma. Journal of International Medical Research, 48, 1-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Pinheiro, P.S., Jones, P.D., Medina, H., Cranford, H.M., Koru-Sengul, T., Bungum, T., et al. (2024) Incidence of Etiology-Specific Hepatocellular Carcinoma: Diverging Trends and Significant Heterogeneity by Race and Ethnicity. Clinical Gastroenterology and Hepatology, 22, 562-571.E8. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Kim, H. and El-Serag, H.B. (2019) The Epidemiology of Hepatocellular Carcinoma in the USA. Current Gastroenterology Reports, 21, Article No. 17. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Piñero, F., Dirchwolf, M. and Pessôa, M.G. (2020) Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment. Cells, 9, Article 1370. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Shibue, T. and Weinberg, R.A. (2017) EMT, Cscs, and Drug Resistance: The Mechanistic Link and Clinical Implications. Nature Reviews Clinical Oncology, 14, 611-629. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Sun, Y., Shao, H., Li, Z., Liu, J., Gao, L., Peng, X., et al. (2004) ZNF268, a Novel Krüppel-Like Zinc Finger Protein, Is Implicated in Early Human Liver Development. International Journal of Molecular Medicine, 14, 971-975. [Google Scholar] [CrossRef]
|
|
[8]
|
Krackhardt, A.M., Witzens, M., Harig, S., Hodi, F.S., Zauls, A.J., Chessia, M., et al. (2002) Identification of Tumor-Associated Antigens in Chronic Lymphocytic Leukemia by SEREX. Blood, 100, 2123-2131. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wang, D., Guo, M., Hu, H., Zhao, Z., Qiu, H., Shao, H., et al. (2008) Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax Represses ZNF268 Expression through the Camp-Responsive Element-Binding Protein/Activating Transcription Factor Pathway. Journal of Biological Chemistry, 283, 16299-16308. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Yao, Z., Shu, L., Yi, Y. and Qiao, L. (2021) Hsa_circRNA_000543 Predicts Poor Prognosis and Promotes Cervical Cancer Cell Progression through Regulating miR-567/ZNF268 Axis. Cancer Management and Research, 13, 5211-5222. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wang, W., Guo, M., Hu, L., Cai, J., Zeng, Y., Luo, J., et al. (2012) The Zinc Finger Protein ZNF268 Is Overexpressed in Human Cervical Cancer and Contributes to Tumorigenesis via Enhancing NF-κB Signaling. Journal of Biological Chemistry, 287, 42856-42866. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Wang, W., Cai, J., Wu, Y., Hu, L., Chen, Z., Hu, J., et al. (2013) Novel Activity of KRAB Domain That Functions to Reinforce Nuclear Localization of KRAB-Containing Zinc Finger Proteins by Interacting with KAP1. Cellular and Molecular Life Sciences, 70, 3947-3958. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Hu, L., Wang, W., Cai, J., Luo, J., Huang, Y., Xiong, S., et al. (2013) Aberrant Expression of ZNF268 Alters the Growth and Migration of Ovarian Cancer Cells. Oncology Letters, 6, 49-54. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Toledo-Leyva, A., Villegas-Pineda, J.C., Encarnación-Guevara, S., Gallardo-Rincón, D. and Talamás-Rohana, P. (2018) Effect of Ovarian Cancer Ascites on SKOV-3 Cells Proteome: New Proteins Associated with Aggressive Phenotype in Epithelial Ovarian Cancer. Proteome Science, 16, Article No. 3. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Benonisson, H., Altıntaş, I., Sluijter, M., Verploegen, S., Labrijn, A.F., Schuurhuis, D.H., et al. (2019) CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory. Molecular Cancer Therapeutics, 18, 312-322. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Xie, P., Zhang, M., He, S., Lu, K., Chen, Y., Xing, G., et al. (2014) The Covalent Modifier Nedd8 Is Critical for the Activation of Smurf1 Ubiquitin Ligase in Tumorigenesis. Nature Communications, 5, Article No. 3733. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Kulik, L. and El-Serag, H.B. (2019) Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology, 156, 477-491.e1. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Giannelli, G., Koudelkova, P., Dituri, F. and Mikulits, W. (2016) Role of Epithelial to Mesenchymal Transition in Hepatocellular Carcinoma. Journal of Hepatology, 65, 798-808. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Li, X., Ramadori, P., Pfister, D., Seehawer, M., Zender, L. and Heikenwalder, M. (2021) The Immunological and Metabolic Landscape in Primary and Metastatic Liver Cancer. Nature Reviews Cancer, 21, 541-557. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Norman, J.S., Li, P.J., Kotwani, P., Shui, A.M., Yao, F. and Mehta, N. (2023) AFP-L3 and DCP Strongly Predict Early Hepatocellular Carcinoma Recurrence after Liver Transplantation. Journal of Hepatology, 79, 1469-1477. [Google Scholar] [CrossRef] [PubMed]
|